Navigation Links
Headphones May Threaten Heart-Device Performance
Date:10/6/2009

Implanted defibrillators, pacemakers may malfunction if headphones hang close to chest, study shows,,

TUESDAY, Oct. 6 (HealthDay News) -- A U.S. study offers more evidence that portable headphones can create magnetic interference that might make implanted defibrillators and pacemakers malfunction.

Using the headphones over the ears doesn't appear to be a problem, but storing them in a shirt or jacket pocket near the chest or allowing them to hang near the heart could spell trouble, researchers found.

The findings should encourage doctors to spend more time talking to their patients about the possible risks of headphones, which could disrupt signaling and threaten lives, the study authors said in a report published in the October issue of the HeartRhythm Journal.

The researchers examined several kinds of portable headphones in 100 patients. They found the level of magnetic interference they emit may be enough to disrupt the devices' ability to detect problems in the heart's rhythm. In other words, the devices could miss an abnormal heart rhythm and fail to reset it to a proper pace.

"As digital music devices continue their current popularity, the risk of device interaction from portable headphones should be accounted for in patients with implantable cardioverter-defibrillators and pacemakers," lead author Dr. William H. Maisel of Beth Israel Deaconess Medical Center at Harvard University, said in a news release from the Heart Rhythm Society. "This study reinforces the need for a doctor-patient dialogue that includes warnings against certain scenarios, such as hanging headphones around the neck or storing them inside a front shirt pocket or jacket pocket."

The headphones caused interference whether or not they were connected to a music player. But the devices worked properly when the patients took off the headphones.

Of the 100 patients studied, 55 had implantable cardioverter
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MP3 Player Headphones May Throw Off Cardiac Devices
2. MP3 headphones interfere with implantable defibrillators, pacemakers
3. Study Shows College Students Are Not Following CDC Recommendations to Help Protect Themselves from H1N1 and Other Threatening Germs
4. Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home
5. Success of National Fundraising Event Critical to Promising Research for Life-Threatening Kidney Disease
6. World Financial Crisis and AIDS Backlash Threaten Lives
7. Hardened Arteries Threaten Obese, Diabetic Youth
8. Senates Proposed Budget Threatens the Health of Millions of Pennsylvanians
9. Dont Let Your Summer Vacation Be Threatened by Guilty Vacation Syndrome
10. Research points to a new way to protect kidneys threatened by insufficient blood or toxins
11. Low-Reimbursement Rate Threatens Wheelchair for Wounded Vets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Our Lady of Lourdes Health Care Services ... has agreed to pay the United States $7.95 million ... Justice Department announced today. The two hospitals are Our ... and Lourdes Medical Center of Burlington County (LMC) in ... a suit brought by a whistleblower, Tony Kite, in ...
(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...
(Date:12/15/2009)... sobering statistics concerning the parallel rise in diabetes and obesity rates ... of combating this trend afflicting their workforce. , ... ... climbing across America due in large part to the alarming parallel ... has stated that the rate of diabetes could be cut in ...
(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...
(Date:12/15/2009)... -- Patient advocate Betsy McCaughey, ... Congress that, "it doesn,t matter whether there,s a public ... a public option - give government authority over how ... a new social agenda by shifting billions of dollars ... arriving immigrants, and local politicians." ,, Betsy ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2
... Scientists have identified the role of two proteins that ... classes of antibiotics. , The finding is a step ... resistance at its cellular source. Before researchers can design ... at play in the conflict between bacteria and the ...
... They wear Prada. They do Pilates.,They primp and pluck. ... other big event -- also take advantage of high-tech ... to Dr. Cameron Rokhsar, a Board-Certified Dermatologic,Surgeon who has ... as in his Upper East Side NY practice, explains ...
... offer up personal history, researchers say , , MONDAY, ... stays in your hair, and it may reveal details ... analyzing the makeup of water molecules from human hair, ... the regions where people recently lived. While the approach ...
... TORRANCE Combined hormone therapy appears to increase the ... biopsies, and it may decrease the effectiveness of both ... in the Feb. 25 issue of Archives of Internal ... Chlebowski, M.D., Ph.D., a lead investigator at the Los ...
... ST. LOUIS, Feb. 25 Stereotaxis, Inc. (Nasdaq:,STXS) announced ... the,fourth quarter and full year ended December 31, 2007, ... Company will host a conference call,and webcast on Wednesday, ... the Company,s fourth quarter results and current corporate,developments. The ...
... living, evading antibiotic drugs while killing tens of thousands of ... about drug-resistant bacteria grows, one novel approach under way at ... thwart the bug without a drug by taking a cue ... analytical chemists at UNC have created nano-scale scaffolds made of ...
Other Medicine News:Health News:Scientists identify proteins that help bacteria put up a fight 2Health News:Scientists identify proteins that help bacteria put up a fight 3Health News:Oscar Makeover CHEAT Secrets of the Stars Revealed 2Health News:Hair Tells Tale of Where You've Been 2Health News:Hair Tells Tale of Where You've Been 3Health News:LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies 2Health News:Silica smart bombs deliver knock-out to bacteria 2
(Date:12/15/2009)... Tenn., Dec. 15 Medical researchers with ... with their revolutionary new technology for a simple ... ,, Following the success of its pre-clinical ... a patent on the biomarker, CA11-19, and all ... blood test, ColoMarker(TM) will detect colon cancer in ...
(Date:12/15/2009)... Tenn., Dec. 15 Cumberland Pharmaceuticals ... announced new top-line results for a patient ... Oral Solution, a prescription laxative packaged as a ... forms. ,, Kristalose is the only prescription-strength laxative ... period, 50 patients with a recent diagnosis of ...
(Date:12/15/2009)... 15 Today,s New York ... for Kidney Drugs Spurs Division," illustrates an internal ... kidney patients continuing to be deprived of their ... program limit. ,, As Congress is poised to ... the lives of transplant kidney recipients, behind-the-scenes debate ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2SemBioSys securityholder vote to be held December 18 2009 with a record date of November 16 2009 14878 1SemBioSys securityholder vote to be held December 18 2009 with a record date of November 16 2009 14878 2SemBioSys securityholder vote to be held December 18 2009 with a record date of November 16 2009 14878 3VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 6356 1VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results 6356 2Cancer patients and doctors report drug side effects differently 61571 1Cancer patients and doctors report drug side effects differently 61571 2
... Combination Clinical Trials ... SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,Pharmaceuticals, Inc. (Nasdaq: ... the company,s lead drug candidate, voreloxin (formerly,SNS-595), including updated results ... single agent in relapsed or refractory patients with acute,myeloid leukemia ...
... 16 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) ... survival,from its Phase 2b clinical trial of CoFactor ... survival results in this,study have been revised upwards ... day improvement in overall survival,compared to the leucovorin/5-FU ...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3
The MYO-VAD is a novel cardiac support system with unique, life-saving features....
... 7500 incorporates SPO Medical's unique reflectance ... for maximum user comfort and ease-of-use. ... for extended usage, eliminating the need ... 7500 downloads stored readings to a ...
ABX Micros IM Hematology Analyzer for a rapid diagnostic...
... Certus guidewire from Radi Medical Systems ... for guiding intervention in patients with ... Reserve (FFR)., ,Enhanced handling properties include ... strengthened core wire linking tip to ...
Medicine Products: